The "Fast Money" traders share their final trades of the day.
Some of the names on the move ahead of the open.
And I'm caught one more time Up on Cyprus Avenue -Van Morrison, "Cyprus Avenue"
TheStreet.com details the 10 best-performing biopharmaceutical stocks of 2012 and their outlook for 2013.
Oct 23- Amgen Inc on Tuesday reported higher-than-expected third-quarter profit in its first full quarter under Chief Executive Robert Bradway and it raised its full-year earnings and revenue forecasts.
*Lazard raises Affymax price target to $28 from $20; rating buy. Reuters Station users, click. 1568. Reuters Station users, click. 4899.
Take a look at some of Tuesday’s morning movers:
Take a look at some of Tuesday’s midday movers:
These heavily shorted stocks could get squeezed way higher if they report positive earnings this week, reports TheStreet.
Cramer makes the call on viewers' favorite stocks.
Following are moves you might have missed. Find out why shares of the China ETF and the New York Times popped while Affymax and Aetna dropped.
Hi folks. Here's a look at the stocks you are buying and trading. The best performing trades by % gain from Monday's close to Tuesday's close were: Valhi : If you bought on Monday at $14.90 and held/sold on Tuesday with a close of $17.93, the contestant gained 20.34% on the trade. Valhi gained almost 13% Monday and Tuesday, followed with another 20% gain...
Dear Valued Player: In the rules for the Million Dollar Portfolio Challenge it is stated that any stocks with a market cap below $500,000,000 after the market close on 3/2/07 would not be eligible for trading in the contest. Because of an error in processing, ten companies were considered eligible for the contest despite being slightly below this market cap floor.